Back
Karyopharm Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
KPTI
Karyopharm Therapeutics, Inc.
Last Price:
$8.79
Seasonality Move:
-7.43%
7 Day Trial
ALL ACCESS PASS
$
7
Karyopharm Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Karyopharm Therapeutics, Inc. has on average historically fallen by 6.6% based on the past 12 years of stock performance.
-
Karyopharm Therapeutics, Inc. has fallen lower in 9 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Karyopharm Therapeutics, Inc. Stock Undervalued?The current Karyopharm Therapeutics, Inc. [KPTI] share price is $8.75. The Score for KPTI is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
KPTI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Karyopharm Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Karyopharm Therapeutics, Inc. has on average historically fallen by 6.6% based on the past 12 years of stock performance.
Karyopharm Therapeutics, Inc. Stock Rating
Sell
45
Karyopharm Therapeutics, Inc. (KPTI)
is a Sell
Is Karyopharm Therapeutics, Inc. overpriced?
-
Karyopharm Therapeutics, Inc. has fallen lower in 9 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Karyopharm Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
karyopharm.com
52-Week Data
52-Week High:
10.99
52-Week Low:
3.51
Prediction Charts
Market Cap:
160.5M
Price in USD:
8.75
Volume:
461.1K
Beta:
0.77
Technical Analysis
SMA50:
7.83
SMA100:
6.95
SMA200:
6.08
52-Wk Change:
17.61%
Stock Predictions
-
Is Karyopharm Therapeutics, Inc. stock public?Yes, Karyopharm Therapeutics, Inc. is a publicly traded company.
-
What is the Karyopharm Therapeutics, Inc. stock quote today?The Karyopharm Therapeutics, Inc. stock price is 8.75 USD today.
-
How to buy Karyopharm Therapeutics, Inc. stock online?You can buy Karyopharm Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-20 | 9.70 | 9.67 | 9.82 | 9.40 |
| Feb-23 | 9.61 | 10.03 | 10.38 | 9.45 |
| Feb-24 | 10.03 | 10.07 | 10.99 | 9.78 |
| Feb-25 | 10.21 | 10.09 | 10.38 | 9.95 |
| Feb-26 | 10.09 | 9.35 | 10.11 | 9.16 |
| Feb-27 | 9.30 | 9.41 | 9.56 | 9.02 |
| Mar-2 | 9.16 | 9.59 | 9.83 | 8.75 |
| Mar-3 | 9.57 | 9.13 | 9.59 | 9.03 |
| Mar-4 | 9.12 | 9.15 | 9.55 | 8.97 |
| Mar-5 | 9.13 | 8.82 | 9.17 | 8.68 |
| Mar-6 | 8.72 | 8.77 | 9.11 | 8.57 |
| Mar-9 | 8.78 | 8.49 | 8.96 | 8.25 |
| Mar-10 | 8.94 | 8.23 | 8.94 | 8.21 |
| Mar-11 | 8.20 | 8.75 | 8.85 | 7.96 |
Karyopharm Therapeutics, Inc. Earnings
Karyopharm Therapeutics, Inc. Earnings Report: Per Share Karyopharm Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Karyopharm Therapeutics, Inc. Forecast Revenue Growth
Karyopharm Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Karyopharm Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $2.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.81 per share, and an increase next year of $1.83 per share.
* Karyopharm Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.